. 2021 Mar 6;21:459. doi: 10.1186/s12889-021-10490-9

Table 4.

Optimal cutoff values, Youden indices, and sensitivity and specificity of obesity indices associated with metabolic abnormalities and their components among HEXA-G participants by sex

	Men				Women
	Optimal cutoff value	Youden’s index	Sensitivity	Specificity	Optimal cutoff value	Youden’s index	Sensitivity	Specificity
Hypertension^a
Body mass index	24.5	0.189	0.596	0.593	23.5	0.246	0.670	0.576
Waist circumference	87.0	0.187	0.570	0.617	78.9	0.255	0.655	0.600
Waist-to-hip ratio	0.896	0.175	0.594	0.581	0.840	0.241	0.662	0.580
Waist-to-height ratio	0.506	0.210	0.662	0.548	0.503	0.275	0.674	0.601
Conicity index	1.24	0.138	0.535	0.604	1.19	0.199	0.607	0.592
Hyperglycemia^b
Body mass index	24.5	0.104	0.567	0.537	24.2	0.207	0.569	0.637
Waist circumference	86.3	0.150	0.591	0.559	80.0	0.272	0.672	0.600
Waist-to-hip ratio	0.895	0.197	0.660	0.537	0.850	0.315	0.710	0.606
Waist-to-height ratio	0.509	0.165	0.634	0.531	0.514	0.288	0.655	0.633
Conicity index	1.23	0.165	0.655	0.510	1.18	0.255	0.728	0.527
Dyslipidemia^c
Body mass index	24.0	0.213	0.654	0.559	23.2	0.198	0.634	0.564
Waist circumference	84.4	0.208	0.675	0.533	77.5	0.219	0.640	0.579
Waist-to-hip ratio	0.879	0.185	0.712	0.474	0.832	0.227	0.652	0.575
Waist-to-height ratio	0.502	0.204	0.661	0.542	0.497	0.228	0.636	0.592
Conicity index	1.20	0.131	0.706	0.425	1.18	0.175	0.608	0.567
Metabolic abnormality^d
Body mass index	24.3	0.241	0.588	0.653	23.4	0.245	0.604	0.641
Waist circumference	84.4	0.248	0.653	0.595	77.0	0.266	0.676	0.590
Waist-to-hip ratio	0.887	0.228	0.639	0.589	0.832	0.270	0.645	0.624
Waist-to-height ratio	0.499	0.259	0.672	0.587	0.496	0.281	0.638	0.644
Conicity index	1.20	0.173	0.698	0.475	1.18	0.210	0.598	0.613

^aSystolic blood pressure higher than 140 mmHg, diastolic blood pressure higher than 90 mmHg or those who reported taking antihypertensive medication

^bFasting glucose higher than 126 mg/dL or those who reported taking antidiabetic medication

^cTriglyceride higher than 150 mg/mL, high-density lipoprotein cholesterol lower than 40 mg/dL or those who reported taking medication for dyslipidemia

^dHaving at least one of the aforementioned factors